SUPN: Supernus Pharma P/E multiplikatori

Supernus Pharma - SUPN emitenti grafik logotipi

Supernus Pharmaceuticals (SUPN) asab tizimi buzilishlarini davolashga ixtisoslashgan. Kompaniyaning GURU.Markets bazaviy grafigidagi joriy bozor P/E ko'rsatkichi 8.40 so'nggi metrika darajasini ifodalovchi ma'lumotlarni o'z ichiga oladi. Biznes neyromeditsinadagi barqaror talabga tayanadi, biroq patent muddatining tugashi xavflari va FDA risklariga duch kelmoqda. Avtonom robotlashtirilgan qadoqlash va aralashtirish liniyalarini joriy etish orqali ishlab chiqarish samaradorligi oshmoqda.

SUPN (Supernus Pharma) P/E multiplikatori tarixi 04.07.2022dan 15.11.2026gacha

Supernus Pharmaceuticals kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning umumiy tahlili:SUPN, Supernus Pharmaceuticals, Inc.
supernus.com yetakchi tovari

P/E koeffitsiyenti aksiyaning joriy bozor narxini kompaniyaning bir aksiyaga to'g'ri keladigan sof foydasi bilan solishtirish orqali investitsiyalarning qoplanish muddatini belgilaydi. Supernus Pharmaceuticals (SUPN) kompaniyasining 12 oylik orqa sirli (TTM) P/E koeffitsiyentini tahlil qilish, klinikalarga sheriklikda innovatsion nevrologik terapiyalar va dori yetkazib berish tizimlarini birgalikda ishlab chiqish bilan bog'liq xarajatlarning ta'sirini hisobga olgan holda, kompaniyaning kapitalizatsiya samaradorligini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Catalyst Pharmaceuticals Inc (CPRX) - Narxning foydaga nisbati|DNLI (Denali Therapeutics Inc) - Narxning foydaga nisbati|Narxning foydaga nisbati Harmony Biosciences Holdings, Inc.|Narxning foydaga nisbati BHVN|Narx-foyda koeffitsiyenti AMLX (Amylyx Pharmaceuticals, Inc.)|Bozor narxining sof foydaga nisbati TRVI|Narxning foydaga nisbati Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Narxning foydaga nisbati|CBLL: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRTA (prothena.com)|Alector, Inc. (ALEC) - Narxning foydaga nisbati|Narx-foyda multiplikatori ANNX|Narxning foydaga nisbati Omeros Corp.|Neurogene Therapeutics (NGNE) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ACIU|VYGR (Voyager Therapeutics) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NMRA (neumoratx.com)|SCLX: Narx-foyda multiplikatori|TVGN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Alpha Cognition Inc.|CGTX: P/E multiplikatori|inhibikase.com (IKT) - P/E multiplikatori|Narxning foydaga nisbati Cassava Sciences Inc|ASRT - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Coya (COYA)|P/E multiplikatori VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati alteritytherapeutics.com ATHE|CLNN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati PepGen Corp (PEPG)|Narxning foydaga nisbati Jupiter Neurosciences, Inc.|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti Grace Tx GRCE|Narxning foydaga nisbati Firefly Neuroscience, Inc AIFF|KLTO: Narx-foyda multiplikatori|NRSN - Narxning foydaga nisbati|RVPH: Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori